The level of protein expression of 19 different DDR, and the post-translationally modified (PTM), phosphorylated forms of 5 of these, was measured in 795 Chronic Lymphocytic Leukemia patients and normalized against the expression of normal CD19 cells as shown in Figure 1. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.